학술논문
Gene-replacement therapy (GRT) in spinal muscular atrophy type 1 (SMA1): Long-term follow-up from the onasemnogene abeparvovec phase 1/2A clinical trial
Document Type
Abstract
Author
Source
In Journal of the Neurological Sciences 15 October 2019 405 Supplement:271-271
Subject
Language
ISSN
0022-510X